The Priority Review

Tag

MDD

1 story

  1. Clinical trials

    Janssen posts results of Phase 3 aticaprant study in major depressive disorder

    Results for the VENTURA-LT study of aticaprant (JNJ-67953964) were first posted on October 6, 2026. The open-label, long-term safety and efficacy study enrolled 871 participants, started on September 22, 2022, and completed primary data collection on April 25, 2025.